Potential concerns with ventoclax and Richter's transformation
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
How can genetic analysis be used to determine chronic lymphocytic leukemia (CLL) treatment?
Recognizing the heterogeneity of DLBCL
Negative-data clinical trials in lymphoma presented at ASH 2015